Aquestive Therapeutics
AQST
#7459
Rank
โ‚ฌ0.44 B
Marketcap
3,54ย โ‚ฌ
Share price
2.41%
Change (1 day)
-1.73%
Change (1 year)

Revenue for Aquestive Therapeutics (AQST)

Revenue in 2026 (TTM): โ‚ฌ42.95 Million

According to Aquestive Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ44.06 Million. In 2025 the company made a revenue of โ‚ฌ37.91 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ55.31 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aquestive Therapeutics from 2017 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ42.95 M13.29%
2025 โ‚ฌ37.91 M-31.45%
2024 โ‚ฌ55.31 M20.89%
2023 โ‚ฌ45.75 M2.94%
2022 โ‚ฌ44.44 M-0.97%
2021 โ‚ฌ44.88 M20.41%
2020 โ‚ฌ37.27 M-20.63%
2019 โ‚ฌ46.96 M-20.32%
2018 โ‚ฌ58.94 M5.68%
2017 โ‚ฌ55.77 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚ฌ0.50 B 1,055.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA